Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of GBP 957.34 million. The enterprise value is 761.49 million.

Market Cap	957.34M
Enterprise Value	761.49M

Important Dates

The next estimated earnings date is Wednesday, September 10, 2025.

Earnings Date	Sep 10, 2025
Ex-Dividend Date	Jun 11, 2025

Share Statistics

Current Share Class	24.32M
Shares Outstanding	n/a
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	23.25M

Valuation Ratios

The trailing PE ratio is 22.03.

PE Ratio	22.03
Forward PE	n/a
PS Ratio	1.43
PB Ratio	2.65
P/TBV Ratio	3.62
P/FCF Ratio	16.00
P/OCF Ratio	13.72
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 12.73.

EV / Earnings	17.52
EV / Sales	1.09
EV / EBITDA	9.26
EV / EBIT	11.31
EV / FCF	12.73

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.10.

Current Ratio	2.33
Quick Ratio	2.26
Debt / Equity	0.10
Debt / EBITDA	0.44
Debt / FCF	0.58
Interest Coverage	42.79

Financial Efficiency

Return on equity (ROE) is 14.95% and return on invested capital (ROIC) is 10.44%.

Return on Equity (ROE)	14.95%
Return on Assets (ROA)	6.94%
Return on Invested Capital (ROIC)	10.44%
Return on Capital Employed (ROCE)	16.45%
Revenue Per Employee	94,559
Profits Per Employee	6,133
Employee Count	7,087
Asset Turnover	1.16
Inventory Turnover	863.92

Taxes

In the past 12 months, Neurones has paid 20.58 million in taxes.

Income Tax	20.58M
Effective Tax Rate	28.24%

Stock Price Statistics

The stock price has increased by +11.69% in the last 52 weeks. The beta is 0.58, so Neurones's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+11.69%
50-Day Moving Average	46.54
200-Day Moving Average	45.24
Relative Strength Index (RSI)	43.24
Average Volume (20 Days)	288

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neurones had revenue of GBP 670.14 million and earned 43.46 million in profits. Earnings per share was 1.79.

Revenue	670.14M
Gross Profit	321.49M
Operating Income	64.36M
Pretax Income	72.86M
Net Income	43.46M
EBITDA	71.88M
EBIT	64.36M
Earnings Per Share (EPS)	1.79

Full Income Statement

Balance Sheet

The company has 270.00 million in cash and 34.75 million in debt, giving a net cash position of 235.25 million.

Cash & Cash Equivalents	270.00M
Total Debt	34.75M
Net Cash	235.25M
Net Cash Per Share	n/a
Equity (Book Value)	360.70M
Book Value Per Share	12.88
Working Capital	277.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 69.78 million and capital expenditures -9.95 million, giving a free cash flow of 59.83 million.

Operating Cash Flow	69.78M
Capital Expenditures	-9.95M
Free Cash Flow	59.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 47.97%, with operating and profit margins of 9.60% and 6.49%.

Gross Margin	47.97%
Operating Margin	9.60%
Pretax Margin	10.87%
Profit Margin	6.49%
EBITDA Margin	10.73%
EBIT Margin	9.60%
FCF Margin	8.93%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 2.40%.

Dividend Per Share	1.10
Dividend Yield	2.40%
Dividend Growth (YoY)	8.72%
Years of Dividend Growth	2
Payout Ratio	55.42%
Buyback Yield	-0.14%
Shareholder Yield	2.27%
Earnings Yield	4.54%
FCF Yield	6.25%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neurones has an Altman Z-Score of 4.36 and a Piotroski F-Score of 6.

Altman Z-Score	4.36
Piotroski F-Score	6